Newsfeeds Archive - Page 19 of 56

2 minute read

Cybin’s FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor

June 28, 2:34 PM

Psychedelics biopharma company Cybin Inc. (NYSE: CYBN) shared its financial results for the fiscal year ended this March 31 as well as recent business highlights. Numbers show: Total cash of $12.5 (CA$16.6) million by March 31, 2023.

CYBN

2 minute read

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets

By Lara Goldstein

June 27, 6:05 PM

Specialty biotech company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA.

FTHWF

1 minute read

Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines

By Lara Goldstein

June 27, 5:00 PM

Australia biotech startup Psylo has inked a sponsored research agreement with global Japanese pharmaceutical company Daiichi Sankyo (OTCMKTS: DSNKY) toward advancing antidepressant psychiatric medicines.

DSNKY

2 minute read

UK Greenlights Phase 2 Clinical Trial On Mindset Pharma’s Psilocin Drug For Major Depression

By Lara Goldstein

June 27, 3:54 PM

Drug discovery company Mindset Pharma (OTCQB: MSSTF) received approval from the U.K.

MSSTF

1 minute read

MindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path Upheld

By Lara Goldstein

June 27, 3:36 PM

MindMed’s (NASDAQ: MNMD) heated proxy battle over R&D strategy might finally be coming to an end.

MNMD

3 minute read

World’s Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees

By Lara Goldstein

June 26, 5:06 PM

The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psy

KONEF

2 minute read

PharmaTher’s Novel Ketamine Heads For The US Market With New Collaboration Agreement

By Lara Goldstein

June 20, 10:38 PM

Psychedelics biotech PharmaTher Holdings (OTCQB: PHRRF) has entered into a collaborative partnership with pharma marketing company Vitruvias Therapeutics for the commercialization of its proprietary racemic ketamine products, KETARX, in the U.S. market.

PHRRF

2 minute read

FSD Pharma Announces Agreement To Grant Exclusive Rights To Recreational Alcohol Misuse Technology

By Lara Goldstein

June 20, 4:48 PM

Biopharma company FSD Pharma (NASDAQ:HUGE) has inked a Letter of Intent (LOI) with private business 1319741 B.C. Ltd.,…

HUGE

2 minute read

MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University

By Lara Goldstein

June 20, 8:43 AM

Numinus Wellness (OTCMKTS: NUMIF) with support from the Multidisciplinary Association for Psychedelic Studies (MAPS) will utilize Optimi Health’s (OTCMKTS: OPTHF) Good Manufacturing Practice (GMP)-compliant MDMA will conduct a therapist-experiential training program.

NUMIF

2 minute read

CNN Goes Psychedelic: Anderson Cooper’s Upcoming Show On Magic Mushrooms

By Lara Goldstein

June 16, 4:23 PM

Psychedelics continue to make their way into the mainstream media. This time they will feature in CNN Anderson Cooper’s upcoming show “The Whole Story.”

NFLX